Caption Management, LLC Rigel Pharmaceuticals Inc Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $231,351 - $1.1 Million	345,300 New	345,300 $390,000
Q1 2022 May 13, 2022	SELL	$2.22 - $3.45 $84,138 - $130,755	-37,900 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.36 - $3.57 $88,972 - $134,589	37,700 Added 18850.0%	37,900 $99,000
Q4 2020 Feb 16, 2021	BUY	$2.35 - $3.74 $470 - $748	200 New	200 $0
Q1 2019 May 14, 2019	SELL	$2.0 - $2.65 $110,000 - $145,750	-55,000 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$2.08 - $3.36 $114,400 - $184,800	55,000 New	55,000 $126,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.